Accendra Health, Inc.
Financials
Valuation Metrics
Accendra Health, Inc.'s Market Cap is $20M. At end of 2025 it was $215M. Ranked #3106 of 3,118 in US market (top 100%), #1643 of 1,644 on NYSE (top 100%), #202 of 203 in Health Care Equipment & Services (top 100%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $20M | US#3,106/3,118 Sec#202/203 |
| Net Income | $-302M | US—/3,118 Sec—/203 |
| Total Assets | $2.11B | US#2,039/3,118 Sec#102/203 |
| Net Assets | $-551M | US#3,015/3,118 Sec#199/203 |
| Employees | 6,500 | US#1,078/3,118 Sec#80/203 |
| Value | ||
| P/S | 0.01x | US#1/3,118 Sec#1/203 |
| EV/EBITDA | 7.81x | US#508/3,118 Sec#14/203 |
| FCF Yield | -1094.86% | US—/3,118 Sec—/203 |
| Profitability | ||
| ROA | -14.34% | US#2,727/3,118 Sec#166/203 |
| Financial Health | ||
| Total Debt | $1.78B | US#1,222/3,118 Sec#61/203 |
| FCF | $-223M | US#2,797/3,118 Sec#199/203 |
| Cash | $8M | US#2,993/3,118 Sec#203/203 |
| Current Ratio | 0.41x | US#2,773/3,118 Sec#205/203 |
| Net Debt/EBITDA | 7.72x | US#2,291/3,118 Sec#138/203 |
| Performance | ||
| 1Y Return | -93.30% | US#3,125/3,118 Sec#203/203 |
| 1M Return | -47.33% | US#3,106/3,118 Sec#202/203 |
| From 52W High | -94.33% | US#3,122/3,118 Sec#205/203 |
| 1Y MDD | -94.78% | US#3,122/3,118 Sec#205/203 |
| Trading | ||
| Volume | 34,086,747 shares | US#1,211/3,118 Sec#70/203 |
| Trading Value | $9M | US#3,083/3,118 Sec#199/203 |
| Per Share | ||
| EPS | $-3.95 | US—/3,118 Sec—/203 |
| BPS | $-7.19 | US—/3,118 Sec—/203 |
Company Info
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods and support services to both healthcare providers and manufacturers. Its extensive catalog includes medical and surgical supplies, featuring both established brands and its own proprietary merchandise. This segment also delivers crucial services to healthcare providers, such as supplier relationship management, advanced analytics, inventory optimization, and clinical supply oversight. Furthermore, it provides outsourced logistics and marketing assistance programs to its vendor partners. The Patient Direct segment is dedicated to delivering products and services for at-home patient care. Its offerings encompass critical therapeutic fields such as diabetes management, home-based respiratory support, and obstructive sleep apnea therapy. This division also supplies various other types of home medical equipment, as well as specialized patient care products for conditions like ostomy, wound management, urological needs, and incontinence. Accendra Health serves a diverse client base directly, including large multi-facility healthcare systems, independent hospitals, surgical facilities, and physicians' practices. Additionally, it reaches customers indirectly through third-party distribution channels. The enterprise was formerly known as Owens & Minor, Inc., adopting the name Accendra Health, Inc. in December 2025. Founded in 1882, its headquarters are located in Glen Allen, Virginia.